Alice Wang

1.4k total citations
35 papers, 933 citations indexed

About

Alice Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Alice Wang has authored 35 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Alice Wang's work include Prostate Cancer Treatment and Research (7 papers), Endometriosis Research and Treatment (4 papers) and Uterine Myomas and Treatments (4 papers). Alice Wang is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Endometriosis Research and Treatment (4 papers) and Uterine Myomas and Treatments (4 papers). Alice Wang collaborates with scholars based in United States, New Zealand and United Kingdom. Alice Wang's co-authors include Mark David, Daniel A. Rappolee, Zena Werb, Lynnette R. Ferguson, Nishi Karunasinghe, Karen Bishop, Shuotun Zhu, Ross Lawrenson, Zuzana Obertová and Jonathan Masters and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Alice Wang

32 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice Wang United States 16 377 190 141 130 116 35 933
Ilma Simoni Brum Brazil 20 319 0.8× 103 0.5× 99 0.7× 101 0.8× 109 0.9× 67 843
Min‐Min Chou Taiwan 19 357 0.9× 209 1.1× 121 0.9× 120 0.9× 94 0.8× 45 1.1k
Hakan Kaya Türkiye 18 199 0.5× 168 0.9× 113 0.8× 53 0.4× 204 1.8× 63 1.1k
Joseph P. McElroy United States 21 343 0.9× 71 0.4× 142 1.0× 112 0.9× 125 1.1× 56 1.0k
Hisashi Horiguchi Japan 20 462 1.2× 173 0.9× 137 1.0× 172 1.3× 188 1.6× 50 1.3k
Zhihong Niu China 16 267 0.7× 138 0.7× 118 0.8× 186 1.4× 98 0.8× 62 924
Ruth H. Paulssen Norway 20 570 1.5× 316 1.7× 77 0.5× 269 2.1× 138 1.2× 52 1.3k
Matthias Ruebner Germany 18 541 1.4× 382 2.0× 84 0.6× 232 1.8× 160 1.4× 54 1.1k

Countries citing papers authored by Alice Wang

Since Specialization
Citations

This map shows the geographic impact of Alice Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Wang more than expected).

Fields of papers citing papers by Alice Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Wang. The network helps show where Alice Wang may publish in the future.

Co-authorship network of co-authors of Alice Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Wang. A scholar is included among the top collaborators of Alice Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Wang. Alice Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gray, Jhanelle E., Nefeli Georgoulia, Alice Wang, et al.. (2023). The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.. Journal of Clinical Oncology. 41(16_suppl). 8541–8541. 1 indexed citations
3.
Camporesi, Elena, Juan Lantero‐Rodriguez, Maria Olsson, et al.. (2023). Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations. Acta Neuropathologica Communications. 11(1). 67–67. 12 indexed citations
4.
Karunasinghe, Nishi, Tsion Z. Minas, Bo‐Ying Bao, et al.. (2022). Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions. Scientific Reports. 12(1). 55–55. 7 indexed citations
5.
Wang, Alice, et al.. (2021). Health Care Costs and Treatment Patterns Associated with Uterine Fibroids and Heavy Menstrual Bleeding: A Claims Analysis. Journal of Women s Health. 31(6). 856–863. 7 indexed citations
6.
Muneyyirci‐Delale, Ozgul, David F. Archer, Charlotte D. Owens, et al.. (2021). Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis. F&S Reports. 2(3). 338–346. 16 indexed citations
7.
Simon, James A., Ayman Al‐Hendy, David F. Archer, et al.. (2020). Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstetrics and Gynecology. 135(6). 1313–1326. 44 indexed citations
8.
Al‐Hendy, Ayman, D.A. Bradley, Charlotte D. Owens, et al.. (2020). Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids. American Journal of Obstetrics and Gynecology. 224(1). 72.e1–72.e50. 26 indexed citations
9.
Karunasinghe, Nishi, et al.. (2019). Selenium Supplementation and Prostate Health in a New Zealand Cohort. Nutrients. 12(1). 2–2. 24 indexed citations
12.
Kao, Chi, Nishi Karunasinghe, Karen Bishop, et al.. (2017). Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men – a genotypic approach. Molecular BioSystems. 13(4). 681–698. 13 indexed citations
13.
Wang, Alice, Lydia Coulter Kwee, Megan L. Neely, et al.. (2017). Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome. Atherosclerosis. 261. 19–25. 27 indexed citations
14.
Karunasinghe, Nishi, et al.. (2016). Prostate Cancer: Is It a Battle Lost to Age?. Geriatrics. 1(4). 27–27. 14 indexed citations
15.
16.
Yau, Christina, John J. Sninsky, Shirley Kwok, et al.. (2013). An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk. Breast Cancer Research. 15(5). R103–R103. 27 indexed citations
17.
Karunasinghe, Nishi, Dug Yeo Han, Karen Bishop, et al.. (2012). Prostate Disease Risk Factors among a New Zealand Cohort. Lifestyle Genomics. 5(6). 339–351. 33 indexed citations
18.
Helms, Mike W., Dirk Kemming, Christopher H. Contag, et al.. (2009). TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer. Cancer Research. 69(12). 5049–5056. 33 indexed citations
19.
Gillett, Cheryl, Paul Cane, Lauren Kam-Morgan, et al.. (2009). A Single-Tube Quantitative Assay for mRNA Levels of Hormonal and Growth Factor Receptors in Breast Cancer Specimens. Journal of Molecular Diagnostics. 11(2). 117–130. 17 indexed citations
20.
Rappolee, Daniel A., Alice Wang, Mark David, & Zena Werb. (1989). Novel method for studying mRNA phenotypes in single or small numbers of cells. Journal of Cellular Biochemistry. 39(1). 1–11. 332 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026